Eagle Pharmaceuticals
NJ - Woodcliff LakePharmaceutical
Focus: Eagle Pharmaceuticals is a public-stage specialty pharma company focused on repurposing existing drugs, primarily in neurology. The company generates 100% of revenue from BENDEKA, a peak-lifecycle chemotherapy agent.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Eagle Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Eagle Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Eagle Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
1 in 5yr
BELRAPZO
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Eagle Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.